Results 21 to 30 of about 41,162 (299)
Prevention of acute kidney injury and protection of renal function in the intensive care unit : update 2017 [PDF]
Background: Acute kidney injury (AKI) in the intensive care unit is associated with significant mortality and morbidity. Objectives: To determine and update previous recommendations for the prevention of AKI, specifically the role of fluids, diuretics ...
Druml, W +8 more
core +5 more sources
ObjectivesWe examined loop diuretic treatment before and 1-year after transcatheter aortic valve implantation (TAVI), as a proxy for changes in symptom severity and secondly assessed how changes in loop diuretics related to mortality risk ...
Xenia Begun +7 more
doaj +1 more source
No studies have examined the impact of multimorbidity and socioeconomic position (SEP) on adherence to the pharmacological therapies following heart transplantation (HTx).
Rikke E. Mols +9 more
doaj +1 more source
European Consensus on use of diuretics in chronic heart failure 2019
The article presents the consensus materials of the European Society of Cardiology on the use of diuretics in chronic heart failure (CHF). Diuretics represent an important class of drugs for the treatment of heart failure from the perspective of evidence
M. V. Leonova
doaj +1 more source
Effect of dapagliflozin on readmission and loop diuretics use in patients with acute heart failure: a retrospective propensity score-matched cohort study. [PDF]
Wu D, Ma Z, Wang X, Wang X, Wang X.
europepmc +3 more sources
Aims Control of pulmonary pressures monitored remotely reduced heart failure hospitalizations mainly by lowering filling pressures through the use of loop diuretics.
Michael Böhm +17 more
doaj +1 more source
Loop diuretics such as furosemide, piretanide, and bumetanide bind reversibly to the Na<sup>+</sup>2Cl<sup>-</sup>K+ carrier. This transporter is responsible for the uptake of Cl<sup>-</sup> into the thick ascending limb segment.
R, Greger, P, Wangemann
openaire +2 more sources
Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis [PDF]
The effect of a sodium glucose cotransporter 2 inhibitor (SGLT2i) in reducing heart failure hospitalization in the EMPA-REG OUTCOMES trial has raised the possibility of using these agents to treat established heart failure.
De Vecchis +22 more
core +1 more source
Prevalence of thiamine deficiency in heart failure patients on long-term diuretic therapy
Background: Loop diuretics are an integral part of heart failure management. It has been shown that loop diuretics cause thiamine deficiency (TD) by increasing its urinary loss. The aim of this study was to determine the prevalence of TD in heart failure
Shrenik Doshi +5 more
doaj +1 more source
Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure [PDF]
Background: Diuretics are the mainstay of treatment for congestion but concerns exist that they adversely affect prognosis. We explored whether the relationship between loop diuretic use and outcome is explained by the underlying severity of ...
A Shoaib +38 more
core +2 more sources

